Cargando…
Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway
BACKGROUND: Reducing drug resistance in tumor cells has become an important issue for cancer treatment. The purpose of this study was to investigate whether IL-22 was involved in lung cancer cell resistance to paclitaxel (PTX), and to explore the underlying molecular mechanism. MATERIAL/METHODS: Non...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952719/ https://www.ncbi.nlm.nih.gov/pubmed/29723165 http://dx.doi.org/10.12659/MSM.907336 |
_version_ | 1783323244923715584 |
---|---|
author | Li, Chenchen Zhao, Xia Yang, Yang Liu, Siwen Liu, Yun Li, Xiaoyou |
author_facet | Li, Chenchen Zhao, Xia Yang, Yang Liu, Siwen Liu, Yun Li, Xiaoyou |
author_sort | Li, Chenchen |
collection | PubMed |
description | BACKGROUND: Reducing drug resistance in tumor cells has become an important issue for cancer treatment. The purpose of this study was to investigate whether IL-22 was involved in lung cancer cell resistance to paclitaxel (PTX), and to explore the underlying molecular mechanism. MATERIAL/METHODS: Non-small cell lung cancer (NSCLC) cell line A549 and the drug resistant cell line A549/PTX were used in the present study. The inhibitory rate of PTX on A549 and A549/PTX cell proliferation was determined by MTT assay and the half-maximal inhibitory concentration (IC(50)) value was calculated. The expression level of IL-22 was detected using Western blot and qRT-PCR. To elucidate the mechanism by which IL-22 is involved in PTX resistance, a stable IL-22-silenced A549/PTX cell line was generated by using IL-22-siRNA. Cell apoptosis was analyzed by flow cytometry, and the c-Jun N-terminal kinase (JNK) signal pathway was determined using Western blot analysis. RESULTS: We found that IL-22 expression level was markedly higher in A549/PTX cells than in A549 cells, and IL-22 gene knockdown significantly enhanced the cell proliferation inhibition rate of PTX to A549/PTX cells and decreased the IC(50) value of PTX to A549/PTX cells, indicating IL-22 was involved in cell PTX resistance. Our findings also suggest that IL-22 knockdown notably increased PTX induced apoptosis in A549/PTX cells. Moreover, the results showed that p-JNK and Caspase 3 expression were significantly increased in IL-22 knockdown A549/PTX cells, while Bcl-2 expression was significantly decreased. CONCLUSIONS: IL-22 is involved in A549 cell resistance to PTX through regulating cell apoptosis via the JNK signaling pathway. |
format | Online Article Text |
id | pubmed-5952719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-59527192018-05-17 Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway Li, Chenchen Zhao, Xia Yang, Yang Liu, Siwen Liu, Yun Li, Xiaoyou Med Sci Monit Lab/In Vitro Research BACKGROUND: Reducing drug resistance in tumor cells has become an important issue for cancer treatment. The purpose of this study was to investigate whether IL-22 was involved in lung cancer cell resistance to paclitaxel (PTX), and to explore the underlying molecular mechanism. MATERIAL/METHODS: Non-small cell lung cancer (NSCLC) cell line A549 and the drug resistant cell line A549/PTX were used in the present study. The inhibitory rate of PTX on A549 and A549/PTX cell proliferation was determined by MTT assay and the half-maximal inhibitory concentration (IC(50)) value was calculated. The expression level of IL-22 was detected using Western blot and qRT-PCR. To elucidate the mechanism by which IL-22 is involved in PTX resistance, a stable IL-22-silenced A549/PTX cell line was generated by using IL-22-siRNA. Cell apoptosis was analyzed by flow cytometry, and the c-Jun N-terminal kinase (JNK) signal pathway was determined using Western blot analysis. RESULTS: We found that IL-22 expression level was markedly higher in A549/PTX cells than in A549 cells, and IL-22 gene knockdown significantly enhanced the cell proliferation inhibition rate of PTX to A549/PTX cells and decreased the IC(50) value of PTX to A549/PTX cells, indicating IL-22 was involved in cell PTX resistance. Our findings also suggest that IL-22 knockdown notably increased PTX induced apoptosis in A549/PTX cells. Moreover, the results showed that p-JNK and Caspase 3 expression were significantly increased in IL-22 knockdown A549/PTX cells, while Bcl-2 expression was significantly decreased. CONCLUSIONS: IL-22 is involved in A549 cell resistance to PTX through regulating cell apoptosis via the JNK signaling pathway. International Scientific Literature, Inc. 2018-05-03 /pmc/articles/PMC5952719/ /pubmed/29723165 http://dx.doi.org/10.12659/MSM.907336 Text en © Med Sci Monit, 2018 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Lab/In Vitro Research Li, Chenchen Zhao, Xia Yang, Yang Liu, Siwen Liu, Yun Li, Xiaoyou Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway |
title | Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway |
title_full | Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway |
title_fullStr | Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway |
title_full_unstemmed | Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway |
title_short | Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway |
title_sort | interleukin-22 (il-22) regulates apoptosis of paclitaxel-resistant non-small cell lung cancer cells through c-jun n-terminal kinase signaling pathway |
topic | Lab/In Vitro Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952719/ https://www.ncbi.nlm.nih.gov/pubmed/29723165 http://dx.doi.org/10.12659/MSM.907336 |
work_keys_str_mv | AT lichenchen interleukin22il22regulatesapoptosisofpaclitaxelresistantnonsmallcelllungcancercellsthroughcjunnterminalkinasesignalingpathway AT zhaoxia interleukin22il22regulatesapoptosisofpaclitaxelresistantnonsmallcelllungcancercellsthroughcjunnterminalkinasesignalingpathway AT yangyang interleukin22il22regulatesapoptosisofpaclitaxelresistantnonsmallcelllungcancercellsthroughcjunnterminalkinasesignalingpathway AT liusiwen interleukin22il22regulatesapoptosisofpaclitaxelresistantnonsmallcelllungcancercellsthroughcjunnterminalkinasesignalingpathway AT liuyun interleukin22il22regulatesapoptosisofpaclitaxelresistantnonsmallcelllungcancercellsthroughcjunnterminalkinasesignalingpathway AT lixiaoyou interleukin22il22regulatesapoptosisofpaclitaxelresistantnonsmallcelllungcancercellsthroughcjunnterminalkinasesignalingpathway |